Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Ardena announced the appointment of Paul Edwards as Chief People Officer. He will lead Ardena’s global people strategy, strengthening organizational capability and supporting the company’s continued international growth.
read more
Monday, November 23, 2020
Seed Therapeutics has entered into a research collaboration and license agreement with Eli Lilly and Company to discover and develop NCEs that could produce therapeutic benefit through TPD.
read more
Friday, November 15, 2013
ordenPharma acquired Ancora Pharmaceuticals, located in Woburn, MA, USA. Ancora’s unique carbohydrate synthesis technology platform and chemistry research facilities perfectly complement CordenPharma’s capabilities in the manufacture and supply of ...
read more
Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system (CNS) and pain, announced that Dennis Dionne (age 66), Executive Director for Commercial...
read more
Tuesday, January 26, 2021
The FDA has issued a guidance to notify drug manufacturers, including repackers, relabelers, alcohol suppliers and compounders, of FDA’s policy on testing of alcohol or isopropyl alcohol for methanol prior to using the ingredient in drugs.
read more
Wednesday, September 08, 2021
National Resilience, a company seeking to build the world’s most advanced biopharmaceutical manufacturing ecosystem, and Moderna announced an agreement to manufacture drug substance for the Moderna COVID-19 vaccine.
read more
Roche today announced that it is expanding access to its clinical trial data for third party researchers. Roche will work with an independent body of recognised experts to evaluate and approve requests to access anonymised patient-level data. Roche ...
read more
Wednesday, August 26, 2015
Amneal has announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC. Amneal Biosciences will focus exclusively on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals.
read more
Phlexglobal, providers of Trial Master File (TMF) technology and services solutions, and LUZ, a language translation company for life sciences, have entered into a partnership to offer a full eTMF and document translation solution.
read more
Friday, September 15, 2017
PCI Pharma Services announced an investment in an expansion of onsite Cold Chain storage at the company’s Philadelphia site.
read more
CNS announced BSP has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme.
read more
Tuesday, October 26, 2021
Ubiquigent Limited (Ubiquigent) today announces the extension and expansion of its long-term collaboration with Bristol Myers Squibb. Under the terms of the agreement, Ubiquigent will provide Bristol Myers Squibb with increased access to its ...
read more
Monday, February 24, 2020
Taro is voluntarily recalling two lots of Phenytoin Oral Suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level.
read more
Thursday, September 05, 2013
Merck, known as MSD outside the United States and Canada, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture bulk varicella at the company’s site in Durham, N.C., for use in Merck’s vaccines ...
read more
Friday, November 09, 2018
Personalis announced the launch of its universal cancer immunogenomics platform, ImmunoID NeXT.
read more